Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
Through this RFP it is our intent to support innovative educational programs that address knowledge gaps and help overcome barriers in the recognition, diagnosis, treatment, and patient education of PI. Projects that will be considered for Pfizer support will focus on advancing patient and HCP education and awareness of PI symptoms, diagnosis, treatment, and outcomes.
Educational initiatives should be focused on primary care practitioners, specialists, infusion nurses, pharmacists, nurse practitioners, physician assistants, and the patients with PI they manage and treat.
Grant Application due date: October 15, 2019